Literature DB >> 35195266

Optimizing the implementation of a multisite feasibility trial of a mind-body program in acute orthopedic trauma.

Jafar Bakhshaie1,2, James Doorley1,2, Mira Reichman1,2, Ryan Mace1,2, David Laverty3, Paul E Matuszewski4, A Rani Elwy5,6, Amirreza Fatehi3, Lucy C Bowers4, Thuan Ly7, Ana-Maria Vranceanu1,2.   

Abstract

The Toolkit for Optimal Recovery (TOR) is a mind-body program for patients with acute orthopedic injuries who are at risk for persistent pain/disability. In preparation for a multisite feasibility trial of TOR at three orthopedic trauma centers, we aim to qualitatively identify barriers and facilitators to study implementation and strategies to mitigate the implementation barriers and leverage facilitators.We conducted 18 live video focus groups among providers and three one-on-one interviews with department chiefs at Level 1 trauma centers in three geographically diverse sites (N = 79 participants). Using a content analysis approach, we detected the site-specific barriers and facilitators of implementation of TOR clinical trial. We organized the data according to 26 constructs of the Consolidated Framework for Implementation Research (CFIR), mapped to three Proctor implementation outcomes relevant to the desired study outcomes (acceptability, appropriateness, and feasibility). Across the three sites, we mapped six of the CFIR constructs to acceptability, eight to appropriateness, and three to feasibility. Prominent perceived barriers across all three sites were related to providers' lack of knowledge/comfort addressing psychosocial factors, and organizational cultures of prioritizing workflow efficiency over patients' psychosocial needs (acceptability), poor fit between TOR clinical trial and the fast-paced clinic structure as well as basic needs of some patients (appropriateness), and limited resources (feasibility). Suggestions to maximize the implementation of the TOR trial included provision of knowledge/tools to improve providers' confidence, streamlining study recruitment procedures, creating a learning collaborative, tailoring the study protocol based on local needs assessments, exercising flexibility in conducting research, dedicating research staff, and identifying/promoting champions and using novel incentive structures with regular check-ins, while keeping study procedures as nonobtrusive and language as de-stigmatizing as possible. These data could serve as a blueprint for implementation of clinical research and innovations in orthopedic and other medical settings. © Society of Behavioral Medicine 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Implementation; Live video; Mind–body; Orthopedic trauma; Reverse translation

Mesh:

Year:  2022        PMID: 35195266      PMCID: PMC9154268          DOI: 10.1093/tbm/ibac004

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.626


  51 in total

1.  Barriers and enablers to conducting cluster randomized control trials in hospitals: A theory-informed scoping review.

Authors:  Arielle Weir; Simon Kitto; Jennifer Smith; Justin Presseau; Ian Colman; Simon Hatcher
Journal:  Eval Program Plann       Date:  2020-03-02

2.  Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.

Authors:  Enola Proctor; Hiie Silmere; Ramesh Raghavan; Peter Hovmand; Greg Aarons; Alicia Bunger; Richard Griffey; Melissa Hensley
Journal:  Adm Policy Ment Health       Date:  2011-03

3.  Use of hospital-based services among young adults with behavioral health diagnoses before and after health insurance expansions.

Authors:  Ellen Meara; Ezra Golberstein; Rebecca Zaha; Shelly F Greenfield; William R Beardslee; Susan H Busch
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

4.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

5.  What Factors Are Associated With Disability After Upper Extremity Injuries? A Systematic Review.

Authors:  Prakash Jayakumar; Celeste L Overbeek; Sarah Lamb; Mark Williams; Christopher J Funes; Stephen Gwilym; David Ring; Ana-Maria Vranceanu
Journal:  Clin Orthop Relat Res       Date:  2018-11       Impact factor: 4.176

6.  The Central Role of Physician Leadership for Driving Change in Value-Based Care Environments.

Authors:  Adam Lustig; Michael Ogden; Robert W Brenner; Jerry Penso; Kimberly D Westrich; Robert W Dubois
Journal:  J Manag Care Spec Pharm       Date:  2016-10

7.  Making sense of implementation theories, models and frameworks.

Authors:  Per Nilsen
Journal:  Implement Sci       Date:  2015-04-21       Impact factor: 7.327

8.  Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions.

Authors:  Thomas J Waltz; Byron J Powell; María E Fernández; Brenton Abadie; Laura J Damschroder
Journal:  Implement Sci       Date:  2019-04-29       Impact factor: 7.327

9.  A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol.

Authors:  Supriya Mohile; Marie Anne Bakitas; Lisa Zubkoff; Kathleen Doyle Lyons; J Nicholas Dionne-Odom; Gregory Hagley; Maria Pisu; Andres Azuero; Marie Flannery; Richard Taylor; Elizabeth Carpenter-Song
Journal:  Implement Sci       Date:  2021-03-11       Impact factor: 7.327

10.  Implementation of a novel vocal cord dysfunction management pathway using the consolidated framework for implementation research.

Authors:  Greg Merlo; Jessica M Suna; Amy McIntosh; Karen Jardine; Louise Kenny; Jennifer Orchard; Mary Wilson; Nelson Alphonso
Journal:  Cardiol Young       Date:  2021-08-05       Impact factor: 1.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.